Open sidebar
Focus
Revance
Companies
|
Reuters
US FDA Declines to Approve Revance’s Frown-Line Treatment
Oct 18, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oct 18
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
|
Reuters
US FDA Declines to Approve Revance’s Frown-Line Treatment
Oct 16, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oct 16
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
